Towards Health Technology Assessment in the Czech Republic
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14560%2F17%3A00096487" target="_blank" >RIV/00216224:14560/17:00096487 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Towards Health Technology Assessment in the Czech Republic
Popis výsledku v původním jazyce
The paper analyzes reasons for the growth of costs of health care and describes one of the methods for regulation of this growth - use of HTA. The Analysis deals with the development and use of HTA in the Czech Republic. The conflict of available resources and innovative technologies in healthcare is performed and methods of HTA are discussed in general introduction. The goal of this article is to reflect the Czech situation in HTA. Th e main issues of HTA assessment in relation to health policy are introduced. The progress of HTA in the Czech Republic is evaluated separately as a process towards to applied pharmacoeconomics and as a process towards HTA. Both the comparative analyses are performed to show the gap in implementing HTA in the Czech Republic. It was found that HTA in the sense o f pharmacoeconomics was implemented (even if Czech Republic does not have a formal HTA body in the sense of an independent agency), however, such a selective use of HTA principles so far has not resulted in the implementation of HTA.
Název v anglickém jazyce
Towards Health Technology Assessment in the Czech Republic
Popis výsledku anglicky
The paper analyzes reasons for the growth of costs of health care and describes one of the methods for regulation of this growth - use of HTA. The Analysis deals with the development and use of HTA in the Czech Republic. The conflict of available resources and innovative technologies in healthcare is performed and methods of HTA are discussed in general introduction. The goal of this article is to reflect the Czech situation in HTA. Th e main issues of HTA assessment in relation to health policy are introduced. The progress of HTA in the Czech Republic is evaluated separately as a process towards to applied pharmacoeconomics and as a process towards HTA. Both the comparative analyses are performed to show the gap in implementing HTA in the Czech Republic. It was found that HTA in the sense o f pharmacoeconomics was implemented (even if Czech Republic does not have a formal HTA body in the sense of an independent agency), however, such a selective use of HTA principles so far has not resulted in the implementation of HTA.
Klasifikace
Druh
D - Stať ve sborníku
CEP obor
—
OECD FORD obor
50200 - Economics and Business
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název statě ve sborníku
Current Trends in Public Sector Research
ISBN
9788021084483
ISSN
2336-1239
e-ISSN
—
Počet stran výsledku
8
Strana od-do
356-363
Název nakladatele
Masarykova univerzita
Místo vydání
Brno
Místo konání akce
Šlapanice
Datum konání akce
1. 1. 2017
Typ akce podle státní příslušnosti
EUR - Evropská akce
Kód UT WoS článku
000402427100046